301060.SZ Stock Analysis
30
Uncovered
Shanghai Labway Clinical Laboratory Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Shanghai Labway Clinical Laboratory Co., Ltd. engages in the provision of medical and pathological examination services. The company is headquartered in Shanghai, Shanghai and currently employs 1,522 full-time employees. The company went IPO on 2021-09-13. The firm's businesses include medical testing and pathological diagnosis services and the sales of in vitro diagnosis product. The medical examination and pathological diagnosis services include pathological diagnosis, molecular examination, biochemical examination, immune examination, microbial examination, clinical basic examination and physical and chemical examination. The in vitro diagnostic products sales include in vitro diagnostic instruments, reagents and related accessories and consumables.